Kết quả tìm kiếm - Nikolas Plevris
- Đang hiển thị 1 - 10 kết quả của 10
-
1
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities Bằng Nikolas Plevris, Charlie W. Lees
Được phát hành 2022Revisão -
2
-
3
Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study Bằng Alexander T. Elford, Maria Bishara, Nikolas Plevris, Beatriz Gros, Nathan Constantine‐Cooke, James Goodhand, Nicholas A. Kennedy, Tariq Ahmad, Charlie W. Lees
Được phát hành 2024Artigo -
4
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort Bằng Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian Arnott, Gareth‐Rhys Jones, Charlie W. Lees, L Derikx
Được phát hành 2023Artigo -
5
Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis Bằng Beatriz Gros, Mairi Goodall, Nikolas Plevris, Nathan Constantine‐Cooke, Alexander T. Elford, Claire O’Hare, Colin Noble, Gareth‐Rhys Jones, Ian Arnott, Charlie W. Lees
Được phát hành 2023Artigo -
6
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis Bằng Rebecca K Grant, Gareth‐Rhys Jones, Nikolas Plevris, Ruairi Lynch, Philip Jenkinson, Charlie W. Lees, Thomas Manship, Fiona Jagger, William M Brindle, M Shivakumar, Jack Satsangi, Ian Arnott
Được phát hành 2020Artigo -
7
IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology Bằng Gareth‐Rhys Jones, Mathew Lyons, Nikolas Plevris, Philip Jenkinson, Cathy Bisset, Christopher Burgess, Shahida Din, James Fulforth, Paul Henderson, Gwo–Tzer Ho, Kathryn Kirkwood, Colin Noble, Alan G. Shand, David C. Wilson, Ian Arnott, Charlie W. Lees
Được phát hành 2019Artigo -
8
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study Bằng Nathaniel A. Cohen, Nikolas Plevris, Uri Kopylov, A Grinman, Bella Ungar, Henit Yanai, Haim Leibovitzh, Naomi Fliss‐Isakov, Ayal Hirsch, Einat Ritter, Yulia Ron, Ariella Bar‐Gil Shitrit, Eran Goldin, Iris Dotan, Shomron Ben–Horin, Charlie W. Lees, Nitsan Maharshak
Được phát hành 2020Artigo -
9
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort Bằng Nikolas Plevris, Cher Shiong Chuah, Rhiannon Allen, Ian Arnott, Paul Brennan, Sardar Chaudhary, A. M. D. Churchhouse, Shahida Din, Emma Donoghue, Daniel R. Gaya, M Groome, Hasnain Jafferbhoy, Philip Jenkinson, Wai Liam Lam, Mathew Lyons, Jonathan Macdonald, M MacMaster, Craig Mowat, Graham Naismith, Lindsay Potts, Eliana Saffouri, John Paul Seenan, Arjun Sengupta, P Shasi, Diarmid Sutherland, John A. Todd, Jennifer Veryan, Angus Watson, David Watts, Gareth‐Rhys Jones, Charlie W. Lees
Được phát hành 2019Artigo -
10
Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy Bằng Uri Kopylov, Jurij Hanžel, Claire Liefferinckx, Davide De Marco, Nicola Imperatore, Nikolas Plevris, Iria Bastón‐Rey, Richard Harris, Marie Truyens, Viktor Domislović, Stephan R. Vavricka, Vince Biemans, Sally Myers, Shaji Sebastian, Shomron Ben–Horin, Yago González Lama, Cyrielle Gilletta, Bar‐Gil Shitrit Ariella, Zuzana Zelinková, Roni Weisshof, Darragh Storan, Eran Zittan, Klaudia Farkas, Tamás Molnár, Denis Franchimont, Anneline Cremer, Waqqas Afif, Fabiana Castiglione, Charlie W. Lees, Manuel Barreiro‐de Acosta, Triana Lobatón, Glen Doherty, Željko Krznarić, Marieke Pierik, Frank Hoentjen, David Drobne
Được phát hành 2020Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Internal medicine
Medicine
Disease
Inflammatory bowel disease
Gastroenterology
Calprotectin
Crohn's disease
Retrospective cohort study
Ulcerative colitis
Cohort
Faecal calprotectin
Adverse effect
Surgery
Cohort study
Colitis
Infliximab
Odds ratio
Vedolizumab
Adalimumab
Autoregressive integrated moving average
Biology
Biosimilar
C-reactive protein
Chemotherapy
Clinical endpoint
Clinical trial
Confidence interval
Demography
Discontinuation
Epidemiology